<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-09-14 03:12:34Clinical research Pharmaceutical industry Design of experiments Medical ethics Institutional review board Clinical trial Pharmacovigilance Office for Human Research Protections Adverse event Human subject research Serious adverse event Adverse effect |
Add to Reading List |
Microsoft Word - Unanticipated_Problems | Regulatory Oversight through HRPP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International ActivitiesDocID: 1rJeK - View Document |
| Microsoft Word - SOP - IRB Membership.docxDocID: 1rrOd - View Document |
| Institutional Review Board . ... . .DocID: 1riwR - View Document |
| RTRN IRB Collaboration Policies and ProceduresDocID: 1rfpb - View Document |
| Visio-AID03H13 HSresearch_reg_definitions rev3.vsdDocID: 1reMP - View Document |